Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001144204-12-025841
Filing Date
2012-05-03
Accepted
2012-05-03 15:22:34
Documents
7
Period of Report
2011-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A v311812_10ka.htm 10-K/A 30677
  Complete submission text file 0001144204-12-025841.txt   2018307

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE DOCUMENT hbmk-20111231.xml EX-101.INS 297771
3 XBRL TAXONOMY EXTENSION SCHEMA hbmk-20111231.xsd EX-101.SCH 19274
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE hbmk-20111231_cal.xml EX-101.CAL 48047
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE hbmk-20111231_def.xml EX-101.DEF 117736
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE hbmk-20111231_lab.xml EX-101.LAB 152221
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hbmk-20111231_pre.xml EX-101.PRE 141691
Mailing Address 55 UBI AVE, #03-01 MINTWELL BUILDING U0 408864
Business Address 55 UBI AVE, #03-01 MINTWELL BUILDING U0 408864 65-6747-7883
Hubei Minkang Pharmaceutical Ltd. (Filer) CIK: 0001375850 (see all company filings)

EIN.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-53231 | Film No.: 12809314
SIC: 2834 Pharmaceutical Preparations